![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Cites Florida Drugmaker for GMP Violations
FDA Cites Florida Drugmaker for GMP Violations
The FDA hit Brooksville, Fla.-based Med-Nap with a Form 483 for lacking proper procedures to prevent product contamination.
An inspection of the drugmaking facility revealed problems with equipment design, including inadequately sealed tanks near sources of dust and a missing ceiling tile near a machine used for manufacturing.
The investigator also observed a maintenance employee making repairs while sitting on a conveyor belt without using a decontamination mat.
Upcoming Events
-
21Oct